Abbott Laboratories (ABT) Amortization - Intangibles (2012 - 2026)

Abbott Laboratories has disclosed Amortization - Intangibles across 15 years of filings, most recently posting $422.0 million for Q1 2026.

• Amortization - Intangibles for Q1 2026 came in at $422.0 million, changed 0.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 7.78% YoY), and the FY2025 annual result was $1.7 billion, down 10.44% from the prior year.
• Amortization - Intangibles came in at $422.0 million for Q1 2026 at Abbott Laboratories, roughly flat from $422.0 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $512.0 million in Q1 2022 to a low of $420.0 million in Q1 2025.
• The 5-year median for Amortization - Intangibles is $472.0 million (2024), against an average of $468.3 million.
• Across the five-year window, Amortization - Intangibles advanced 0.6% in 2022 and dropped 11.02% in 2025, its largest moves.
• Abbott Laboratories' Amortization - Intangibles stood at $496.0 million in 2022, then fell by 3.02% to $481.0 million in 2023, then retreated by 3.33% to $465.0 million in 2024, then retreated by 9.25% to $422.0 million in 2025, then changed by 0.0% to $422.0 million in 2026.
• The last three Amortization - Intangibles figures came in at $422.0 million (Q1 2026), $422.0 million (Q4 2025), and $420.0 million (Q3 2025), per Business Quant data.